{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:52:03Z","timestamp":1780624323303,"version":"3.54.1"},"publisher-location":"Cham","reference-count":100,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030890735","type":"print"},{"value":"9783030890742","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/164_2020_420","type":"book-chapter","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T15:37:04Z","timestamp":1607528224000},"page":"275-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans"],"prefix":"10.1007","author":[{"given":"Saadet","family":"Inan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"420_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-1879","volume":"95","author":"T Akiyama","year":"2015","unstructured":"Akiyama T, Carstens ML, Piecha D, Stepan S, Carstens E (2015) Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice. Acta Derm Venereol 95:147\u2013150","journal-title":"Acta Derm Venereol"},{"key":"420_CR2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/BF03019227","volume":"44","author":"JA Alhashemi","year":"1997","unstructured":"Alhashemi JA, Crosby ET, Grodecki W, Duffy PJ, Hull KA, Gallant C (1997) Treatment of intrathecal morphine-induced pruritus following cesarean section. Can J Anaesth 44:1060\u20131065","journal-title":"Can J Anaesth"},{"key":"420_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/exd.12222","volume":"22","author":"I Arai","year":"2013","unstructured":"Arai I, Tsuji M, Takeda H, Akiyama N, Saito S (2013) A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice. Exp Dermatol 22:669\u2013671","journal-title":"Exp Dermatol"},{"key":"420_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/jid.1955.138","volume":"25","author":"RP Arthur","year":"1955","unstructured":"Arthur RP, Shelley WB (1955) The role of proteolytic enzymes in the production of pruritus in man. J Invest Dermatol 25:341\u2013346","journal-title":"J Invest Dermatol"},{"key":"420_CR5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00000542-198102000-00007","volume":"54","author":"A Baraka","year":"1981","unstructured":"Baraka A, Noueihid R, Hajj S (1981) Intrathecal injection of morphine for obstetric analgesia. Anesthesiology 54:136\u2013140","journal-title":"Anesthesiology"},{"key":"420_CR6","first-page":"487","volume":"204","author":"WT Beaver","year":"1978","unstructured":"Beaver WT, Feise GA (1978) A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain. J Pharmacol Exp Ther 204:487\u2013496","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/clpt.1981.28","volume":"29","author":"WT Beaver","year":"1981","unstructured":"Beaver WT, Feise GA (1981) Analgesic effect of intramuscular and oral nalbuphine in postoperative pain. Clin Pharmacol Ther 29:174\u2013180","journal-title":"Clin Pharmacol Ther"},{"key":"420_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0168-8278(92)90040-V","volume":"15","author":"NV Bergasa","year":"1992","unstructured":"Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA (1992) Central mu-opioid receptors are down-regulated in a rat model of cholestasis. J Hepatol 15:220\u2013224","journal-title":"J Hepatol"},{"key":"420_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.119.256354","volume":"370","author":"ER Butelman","year":"2019","unstructured":"Butelman ER, McElroy BD, Prisinzano TE, Kreek MJJ (2019) Impact of pharmacological manipulation of the k-opioid receptor system on self-grooming and anhedonic-like behaviors in mice. J Pharmacol Exp Ther 370:1\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/physrev.00017.2019","volume":"100","author":"F Cevikbas","year":"2020","unstructured":"Cevikbas F, Lerner EA (2020) Physiology and pathophysiology of itch. Physiol Rev 100:945\u2013982","journal-title":"Physiol Rev"},{"key":"420_CR11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","volume":"133","author":"F Cevikbas","year":"2014","unstructured":"Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V, Feld M, Alenius H, Dillon SR, Carstens E, Homey B, Basbaum A, Steinhoff M (2014) A sensory neuron-expressed interleukin-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133:448\u2013460","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF03011037","volume":"42","author":"MA Chaney","year":"1995","unstructured":"Chaney MA (1995) Side effects of intrathecal and epidural opioids. Can J Anaesth 42:891\u2013903","journal-title":"Can J Anaesth"},{"key":"420_CR13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaad.2019.09.014","volume":"82","author":"AS Chiou","year":"2020","unstructured":"Chiou AS, Choi S, Barriga M, Dutt-Singkh Y, Solis DC, Nazaroff J, Bailey-Healy I, Li S, Shu K, Joing M, Kwon P, Tang JY (2020) Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: a randomized clinical trial. J Am Acad Dermatol 82:1415\u20131421","journal-title":"J Am Acad Dermatol"},{"key":"420_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-6147(86)90257-9","volume":"7","author":"A Cowan","year":"1988","unstructured":"Cowan A, Gmerek DE (1988) In-vivo studies on kappa opioid receptors. Trends Pharmacol Sci 7:69\u201372","journal-title":"Trends Pharmacol Sci"},{"key":"420_CR15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/978-1-59745-197-0_28","volume-title":"Opiate receptors and antagonists: from bench to clinic","author":"A Cowan","year":"2009","unstructured":"Cowan A, Inan S (2009) Kappa-opioid antagonists as pruritogenic agents. In: Dean R, Bilsky EJ, Negus SS (eds) Opiate receptors and antagonists: from bench to clinic. Humana\/Springer Press, New York, pp 541\u2013549"},{"key":"420_CR16","unstructured":"Cowan A, Kehner GB (1997) Antagonism by opioids of compound 48\/80-induced scratching in mice. Br J Pharmacol 122(Suppl):169P"},{"key":"420_CR17","first-page":"A51","volume":"44","author":"A Cowan","year":"2002","unstructured":"Cowan A, Inan S, Kehner GB (2002) GNTI, a kappa opioid receptor antagonist, causes compulsive scratching in mice. The Pharmacologist 44:A51","journal-title":"The Pharmacologist"},{"key":"420_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2015.09.055","volume":"310","author":"A Cowan","year":"2015","unstructured":"Cowan A, Lyu L-M, Chen YH, Dun SL, Chang J-K, Dun NJ (2015) Phoenixin: a candidate pruritogen in the mouse. Neuroscience 310:541\u2013548","journal-title":"Neuroscience"},{"key":"420_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2014.01.022","volume":"563","author":"KM DiMattio","year":"2014","unstructured":"DiMattio KM, Yakovleva TV, Aldrich JV, Cowan A, Liu-Chen LY (2014) Zyklophin, a short-acting kappa opioid antagonist, induces scratching in mice. Neurosci Lett 563:155\u2013159","journal-title":"Neurosci Lett"},{"key":"420_CR20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jdermsci.2016.09.008","volume":"84","author":"G Elliott","year":"2016","unstructured":"Elliott G, Vanwersch R, Soeberdt M, Metze D, Lotts T, St\u00e4nder S, Abels C (2016) Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD. J Dermatol Sci 84:351\u2013354","journal-title":"J Dermatol Sci"},{"key":"420_CR21","first-page":"30","volume":"316","author":"T Endoh","year":"1992","unstructured":"Endoh T, Matsuura H, Tanaka C, Nagase H (1992) Nor-Binaltorphimine: a potent and selective \u039a-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316:30\u201342","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"420_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1912770","volume":"382","author":"S Fishbane","year":"2020","unstructured":"Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F (2020) A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med 382:22\u2013232","journal-title":"N Engl J Med"},{"key":"420_CR23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2014.03.062","volume":"579","author":"K Fua","year":"2014","unstructured":"Fua K, Qu L, Shimada SG, Nie H, LaMotte RH (2014) Enhanced scratching elicited by a pruritogen and an algogen in a mouse model of contact hypersensitivity. Neurosci Lett 579:190\u2013194","journal-title":"Neurosci Lett"},{"key":"420_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0160-5402(83)90073-6","volume":"10","author":"DE Gmerek","year":"1983","unstructured":"Gmerek DE, Cowan A (1983) An animal model for preclinical screening of systemic antipruritic agents. J Pharmacol Methods 10:107\u2013112","journal-title":"J Pharmacol Methods"},{"key":"420_CR25","first-page":"110","volume":"230","author":"DE Gmerek","year":"1984","unstructured":"Gmerek DE, Cowan A (1984) In vivo evidence for benzomorphan-selective receptors in rats. J Pharmacol Exp Ther 230:110\u2013115","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR26","first-page":"428","volume":"242","author":"DE Gmerek","year":"1987","unstructured":"Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys. III Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428\u2013436","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0625.2008.00766.x","volume":"18","author":"O Grimstad","year":"2009","unstructured":"Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen BU, Gr\u00f8nh\u00f8j-Larsen C, Matsushima K (2009) Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC\/Nga mice: a model of atopic dermatitis. Exp Dermatol 18:35\u201343","journal-title":"Exp Dermatol"},{"key":"420_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","volume":"156","author":"E Guttman-Yassky","year":"2020","unstructured":"Guttman-Yassky E, Blauvelt A, Eichenfield LF, Paller AS, Armstrong AW, Drew J, Gopalan R, Simpson EL (2020) Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial. JAMA Dermatol 156:411\u2013420","journal-title":"JAMA Dermatol"},{"key":"420_CR29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaci.2019.04.005","volume":"144","author":"T Hashimoto","year":"2019","unstructured":"Hashimoto T, Yosipovitch G (2019) Itching as a systemic disease. J Allergy Clin Immunol 144:375\u2013380","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR30","first-page":"634","volume":"93","author":"A Hawi","year":"2013","unstructured":"Hawi A, Hunter R, Morpford L, Sciascia T (2013) Nalbuphine attenuates itch in the substance-P-induced mouse model. Acta Derm Venereol 93:634","journal-title":"Acta Derm Venereol"},{"key":"420_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12882-015-0043-3","volume":"16","author":"A Hawi","year":"2015","unstructured":"Hawi A, Alcorn H Jr, Berg J, Hines C, Hait H, Sciascia T (2015) Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus. BMC Nephrol 16:47","journal-title":"BMC Nephrol"},{"key":"420_CR32","unstructured":"Inan S (2010) Pharmacological and neuroanatomical analysis of GNTI-induced repetitive behavior in mice. PhD thesis, Temple University, Philadelphia 78"},{"key":"420_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2004.09.010","volume":"502","author":"S Inan","year":"2004","unstructured":"Inan S, Cowan A (2004) Kappa opioid agonists suppress chloroquine-induced scratching in mice. Eur J Pharmacol 502:233\u2013237","journal-title":"Eur J Pharmacol"},{"key":"420_CR34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2005.06.025","volume":"518","author":"S Inan","year":"2005","unstructured":"Inan S, Cowan A (2005) Reduced kappa-opioid activity in a rat model of cholestasis. Eur J Pharmacol 518:182\u2013186","journal-title":"Eur J Pharmacol"},{"key":"420_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2006.07.004","volume":"85","author":"S Inan","year":"2006","unstructured":"Inan S, Cowan A (2006) Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Boichem Behav 85:39\u201343","journal-title":"Pharmacol Boichem Behav"},{"key":"420_CR36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2009.06.026","volume":"616","author":"S Inan","year":"2009","unstructured":"Inan S, Dun NJ, Cowan A (2009a) Inhibitory effect of lidocaine on pain and itch using formalin induced nociception and 5\u2032-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence. Eur J Pharmacol 616:141\u2013146","journal-title":"Eur J Pharmacol"},{"key":"420_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2009.06.016","volume":"163","author":"S Inan","year":"2009","unstructured":"Inan S, Dun NJ, Cowan A (2009b) Nalfurafine prevents GNTI- and compound 48\/80-induced spinal cfos expression and attenuates GNTI-elicited scratching behavior in mice. Neuroscience 163:23\u201333","journal-title":"Neuroscience"},{"key":"420_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00210-008-0358-8","volume":"379","author":"S Inan","year":"2009","unstructured":"Inan S, Lee DYW, Liu-Chen LY, Cowan A (2009c) Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin a. Naunyn Schmiedeberg\u2019s Arch Pharmacol 379:263\u2013270","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"420_CR39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.peptides.2010.11.022","volume":"32","author":"S Inan","year":"2011","unstructured":"Inan S, Dun NJ, Cowan A (2011) Investigation of gastrin-releasing peptide as a mediator for 5\u2032-Guanidinonaltrindole-induced compulsive scratching in mice. Peptides 32:286\u2013292","journal-title":"Peptides"},{"key":"420_CR40","doi-asserted-by":"crossref","first-page":"172702","DOI":"10.1016\/j.ejphar.2019.172702","volume":"864","author":"S Inan","year":"2019","unstructured":"Inan S, Huerto AT, Jensen LE, Dun NJ, Cowan A (2019) Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. Eur J Pharmacol 864:172702","journal-title":"Eur J Pharmacol"},{"key":"420_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2133.1963.tb13948.x","volume":"75","author":"GV Joglekar","year":"1963","unstructured":"Joglekar GV, Bhide MB, Balwani JH (1963) An experimental method for screening antipruritic agents. Br J Dermatol 75:117\u2013119","journal-title":"Br J Dermatol"},{"key":"420_CR42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/qjmed\/95.8.547","volume":"95","author":"EA Jones","year":"2002","unstructured":"Jones EA, Neuberger J, Bergasa NV (2002) Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 95:547\u2013552","journal-title":"QJM"},{"key":"420_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(01)00941-4","volume":"418","author":"J Kamei","year":"2001","unstructured":"Kamei J, Nagase H (2001) Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 418:141\u2013145","journal-title":"Eur J Pharmacol"},{"key":"420_CR44","volume":"12","author":"K Kamimura","year":"2017","unstructured":"Kamimura K, Yokoo T, Kamimura H, Sakamaki A, Abe S, Tsuchiya A, Takamura M, Kawai H, Yamagiwa S, Terai S (2017) Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: patient-reported outcome based analyses. PLoS One 12:e0178991","journal-title":"PLoS One"},{"key":"420_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuron.2014.02.046","volume":"82","author":"AP Kardon","year":"2014","unstructured":"Kardon AP, Polgar E, Hachisuka J, Snyder LM, Cameron D, Savage S, Cai X, Karnup S, Fan CR, Hemenway GM, Bernard CS, Schwartz ES, Nagase H, Schwarzer C, Watanabe M, Furuta T, Kaneko T, Koerber HR, Todd AJ, Ross SE (2014) Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord. Neuron 82:573\u2013586","journal-title":"Neuron"},{"key":"420_CR46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.108.143925","volume":"328","author":"MC Ko","year":"2009","unstructured":"Ko MC, Husbands SM (2009) Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 328:193\u2013200","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00000542-200003000-00023","volume":"92","author":"MCH Ko","year":"2000","unstructured":"Ko MCH, Naughton NN (2000) An experimental itch model in monkeys. Characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology 92:795\u2013805","journal-title":"Anesthesiology"},{"key":"420_CR48","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","volume":"25","author":"H Kumagai","year":"2010","unstructured":"Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H (2010) Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 25:1251\u20131257","journal-title":"Nephrol Dial Transplant"},{"key":"420_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","volume":"36","author":"H Kumagai","year":"2012","unstructured":"Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Hidetomi N, Kurihara M, Yanagita T, Suzuki H (2012) Efficacy and safety of a novel \u0138-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol 36:175\u2013183","journal-title":"Am J Nephrol"},{"key":"420_CR50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)00780-B","volume":"275","author":"Y Kuraishi","year":"1995","unstructured":"Kuraishi Y, Nagasawa T, Hayashi K, Satoh M (1995) Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 275:229\u2013233","journal-title":"Eur J Pharmacol"},{"key":"420_CR51","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1073\/pnas.0604575103","volume":"103","author":"M Li","year":"2006","unstructured":"Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P (2006) Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci 103:11736\u201311741","journal-title":"Proc Natl Acad Sci"},{"key":"420_CR52","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","volume":"139","author":"Q Liu","year":"2009","unstructured":"Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ, Dong X (2009) Sensory neuron-specific GPCRs Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139:1353\u20131365","journal-title":"Cell"},{"key":"420_CR53","doi-asserted-by":"crossref","unstructured":"Liu Q, Weng HJ, Patel KN, Tang Z, Bai H, Steinhoff M, Dong X (2011) The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci Signal 4:ra45","DOI":"10.1126\/scisignal.2001925"},{"key":"420_CR54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-018-0155-0","volume":"44","author":"JJ Liu","year":"2019","unstructured":"Liu JJ, Chiu YT, DiMattio KM, Chen C, Huang P, Gentile TA, Muschamp JW, Cowan A, Mann M, Liu-Chen LY (2019) Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in \u03ba opioid aversion. Neuropsychopharmacology 44:939\u2013949","journal-title":"Neuropsychopharmacology"},{"key":"420_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jid.5701011","volume":"128","author":"MQ Man","year":"2008","unstructured":"Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Donald YML, Holleran W, Uchida Y, Elias PM (2008) Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 128:79\u201386","journal-title":"J Invest Dermatol"},{"key":"420_CR56","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2340\/00015555-1159","volume":"91","author":"U Matterne","year":"2011","unstructured":"Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, B\u00fcttner M, Ofenloch R, Diepgen TL, Weisshaar E (2011) Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 91:674\u2013679","journal-title":"Acta Derm Venereol"},{"key":"420_CR57","volume":"8","author":"J Meixiong","year":"2009","unstructured":"Meixiong J, Vasavda C, Green D, Zheng Q, Qi L, Kwatra SG, Hamilton JP, Snyder HS, Dong X (2009a) Identification of a bilirubin receptor that may mediate a component of cholestatic itch. elife 8:e44116","journal-title":"elife"},{"key":"420_CR58","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.1903316116","volume":"116","author":"J Meixiong","year":"2009","unstructured":"Meixiong J, Vasavda C, Snyder HS, Dong X (2009b) MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus. Proc Natl Acad Sci 116:10525\u201310530","journal-title":"Proc Natl Acad Sci"},{"key":"420_CR59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.88.285","volume":"88","author":"T Miyamoto","year":"2002","unstructured":"Miyamoto T, Nojima H, Shinkado T, Nakahashi T, Kuraishi Y (2002) Itch-associated response induced by experimental dry skin in mice. Jpn J Pharmacol 88:285\u2013292","journal-title":"Jpn J Pharmacol"},{"key":"420_CR60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuropharm.2015.08.027","volume":"99","author":"J Morgenweck","year":"2015","unstructured":"Morgenweck J, Frankowski KJ, Prisinzano TE, Aub\u00e9 J, Bohn LM (2015) Investigation of the role of \u03b2arrestin2 in kappa opioid receptor modulation in a mouse model of pruritus. Neuropharmacology 99:600\u2013609","journal-title":"Neuropharmacology"},{"key":"420_CR61","doi-asserted-by":"publisher","unstructured":"Mueller SM, Gantenbein L, Navarini A, St\u00e4nder S, Jacob A, Popko L (2020) The first mention of itch in history? When Egyptologists scratch their heads. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.16133","DOI":"10.1111\/jdv.16133"},{"key":"420_CR62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1248\/cpb.46.366","volume":"46","author":"H Nagase","year":"1998","unstructured":"Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T (1998) Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull (Tokyo) 46:366\u2013369","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"420_CR63","first-page":"75","volume":"28","author":"K Nakao","year":"2008","unstructured":"Nakao K, Ikeda K, Kurokawa T, Togashi Y, Umeuchi H, Honda T, Okano K, Mochizuki H (2008) Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis. Nihon Shinkei Seishin Yakurigaku Zasshi 28:75\u201383","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"420_CR64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/jpet.103.049239","volume":"306","author":"H Nojima","year":"2003","unstructured":"Nojima H, Cartens E (2003) 5-Hydroxytryptamine (5-HT)2 receptor involvement in acute 5-HT-evoked scratching but not in allergic pruritus induced by dinitrofluorobenzene in rats. J Pharmacol Exp Ther 306:245\u2013252","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR65","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1440-1681.12752","volume":"44","author":"S Ostadhadi","year":"2017","unstructured":"Ostadhadi S, Haddadi NS, Foroutan A, Azimi E, Elmariah S, Dehpour AR (2017) Development of resistance to serotonin-induced itch in bile duct ligated mice. Clin Exp Pharmacol Physiol 44:680\u2013685","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"420_CR66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaad.2020.01.056","volume":"82","author":"DM Pariser","year":"2020","unstructured":"Pariser DM, Bagel J, Lebwohl M, Yosipovitch G, Chien E, Spellman MC (2020) Serlopitant for psoriatic pruritus: a phase 2 randomized, double-blind, placebo-controlled clinical trial. J Am Acad Dermatol 82:1314\u20131320","journal-title":"J Am Acad Dermatol"},{"key":"420_CR67","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2017.205","volume":"43","author":"B Reed","year":"2018","unstructured":"Reed B, Butelman ER, Fry RS, Kimani R, Kreek MJ (2018) Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence. Neuropsychopharmacology 43:739\u2013750","journal-title":"Neuropsychopharmacology"},{"key":"420_CR68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5826\/dpc.0902a03","volume":"9","author":"G Rinaldi","year":"2019","unstructured":"Rinaldi G (2019) The itch-scratch cycle: a review of the mechanisms. Dermatol Pract Concept 9:90\u201397","journal-title":"Dermatol Pract Concept"},{"key":"420_CR69","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1097\/j.pain.0000000000000674","volume":"157","author":"K Sakai","year":"2016","unstructured":"Sakai K, Sanders KM, Youssef MR, Yanushefski KM, Jensen L, Yosipovitch G, Akiyama T (2016) Mouse model of imiquimod-induced psoriatic itch. Pain 157:2536\u20132543","journal-title":"Pain"},{"key":"420_CR70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/AAP.0000000000000326","volume":"41","author":"M Sakakihara","year":"2016","unstructured":"Sakakihara M, Imamachi N, Saito Y (2016) Effects of intrathecal \u03ba-opioid receptor agonist on morphine-induced itch and antinociception in mice. Reg Anesth Pain Med 41:69\u201374","journal-title":"Reg Anesth Pain Med"},{"key":"420_CR71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0376-8716(85)90066-3","volume":"14","author":"WK Schmidt","year":"1985","unstructured":"Schmidt WK, Tam SW, Shotzberger GS, Dewey HS, Clark R, Vernier VG (1985) Nalbuphine. Drug Alcohol Depend 14:339\u2013362","journal-title":"Drug Alcohol Depend"},{"key":"420_CR72","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.08.002","volume":"139","author":"SG Shimada","year":"2008","unstructured":"Shimada SG, LaMotte RH (2008) Behavioral differentiation between itch and pain in mouse. Pain 139:681\u2013687","journal-title":"Pain"},{"key":"420_CR73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejphar.2005.11.012","volume":"530","author":"SG Shimada","year":"2006","unstructured":"Shimada SG, Shimada KA, Collins JG (2006) Scratching behavior in mice induced by the proteinaseactivated receptor-2 agonist, SLIGRL-NH2. Eur J Pharmacol 530:281\u2013283","journal-title":"Eur J Pharmacol"},{"key":"420_CR74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2019.08.013","volume":"145","author":"JI Silverberg","year":"2020","unstructured":"Silverberg JI, Pinter A, Pulka G, Poulin Y, Bouaziz JD, Wollenberg A, Murrell DF, Alexis A, Lindsey L, Ahmad F, Piketty C, Clucas A (2020) Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. J Allergy Clin Immunol 145:173\u2013182","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR75","doi-asserted-by":"publisher","unstructured":"Soeberdt M, Kilic A, Abels C (2020) Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173242","DOI":"10.1016\/j.ejphar.2020.173242"},{"key":"420_CR76","unstructured":"Spencer R, Mathur V, Stauffer JW, Menzaghi F (2015) Decrease of itch intensity by CR845, a novel kappa opioid receptor agonist. In: 8th world congress on itch, 25\u201327 September 2015, Nara"},{"key":"420_CR77","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/exd.13953","volume":"28","author":"S St\u00e4nder","year":"2019","unstructured":"St\u00e4nder S (2019) How to define chronic pruritus: symptom or disease? Exp Dermatol 28:1461\u20131465","journal-title":"Exp Dermatol"},{"key":"420_CR78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","volume":"87","author":"S St\u00e4nder","year":"2007","unstructured":"St\u00e4nder S, Weisshaar E, Mettang T, Szepietowski JC, Carsten E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD (2007) Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol 87:291\u2013294","journal-title":"Acta Derm Venereol"},{"key":"420_CR79","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","volume":"448","author":"YG Sun","year":"2007","unstructured":"Sun YG, Chen ZF (2007) A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448:700\u2013703","journal-title":"Nature"},{"key":"420_CR80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000053599","volume":"1","author":"H Suto","year":"1999","unstructured":"Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Ra C (1999) NC\/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1:70\u201375","journal-title":"Int Arch Allergy Immunol"},{"key":"420_CR81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0625.2006.00405.x","volume":"15","author":"A Takaoka","year":"2006","unstructured":"Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, Nakamura A, Nakaike S (2006) Involvement of IL-31 on scratching behavior in NC\/Nga mice with atopic-like dermatitis. Exp Dermatol 15:161\u2013167","journal-title":"Exp Dermatol"},{"key":"420_CR82","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejphar.2008.10.040","volume":"601","author":"M Terakawa","year":"2008","unstructured":"Terakawa M, Fujieda Y, Tomimori Y, Muto T, Tanaka T, Maruoka H, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y (2008) Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis. Eur J Pharmacol 601:186\u2013191","journal-title":"Eur J Pharmacol"},{"key":"420_CR83","doi-asserted-by":"publisher","first-page":"36286","DOI":"10.1038\/srep36286","volume":"6","author":"B Tian","year":"2016","unstructured":"Tian B, Wang XL, Huang Y, Chen LH, Chen RX, Zhou FM, Guo R, Li JC, Liu T (2016) Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats. Sci Rep 6:36286. https:\/\/doi.org\/10.1038\/srep36286","journal-title":"Sci Rep"},{"key":"420_CR84","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","volume":"435","author":"Y Togashi","year":"2002","unstructured":"Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H (2002) Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol 435:259\u2013264","journal-title":"Eur J Pharmacol"},{"key":"420_CR85","doi-asserted-by":"crossref","unstructured":"Trauner M, Wagner M, Fickert P, Zollner G (2005) Molecular regulation of hepatobiliary transport systems. Clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39(Suppl II):S111\u2013S124","DOI":"10.1097\/01.mcg.0000155551.37266.26"},{"key":"420_CR86","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jopan.2018.06.098","volume":"34","author":"TD Tubog","year":"2019","unstructured":"Tubog TD, Harenberg JL, Buszta K, Hestand JD (2019) Prophylactic nalbuphine to prevent neuraxial opioid-induced pruritus: a systematic review and meta-analysis of randomized controlled trials. J Perianesth Nurs 34:491\u2013501","journal-title":"J Perianesth Nurs"},{"key":"420_CR87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5414\/CP201852","volume":"51","author":"Y Ueno","year":"2013","unstructured":"Ueno Y, Mori A, Yanagita T (2013) One year long-term study on abuse liability of nalfurafine in hemodialysis patients. Int J Clin Pharmacol Ther 51:823\u2013831","journal-title":"Int J Clin Pharmacol Ther"},{"key":"420_CR88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.06.019","volume":"518","author":"H Umeuchi","year":"2005","unstructured":"Umeuchi H, Kawashima Y, Aoki CA, Kurokawa T, Nakao K, Itoh M, Kikuchi K, Kato T, Okano K, Gershwin ME, Miyakawa H (2005) Spontaneous scratching behavior in MRL\/lpr mice, a possible model forpruritus in autoimmune diseases, and antipruritic activity of a novel \u03ba-opioid receptor agonist nalfurafine hydrochloride. Eur J Pharmacol 518:133\u2013139","journal-title":"Eur J Pharmacol"},{"key":"420_CR89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","volume":"583","author":"TW Vanderah","year":"2008","unstructured":"Vanderah TW, Largent-Milnes T, Lai J, Porreca F, Houghten RA, Menzaghi F, Wisniewski K, Stalewski J, Sueiras-Diaz J, Galyean R, Schteingart C, Junien JL, Trojnar J, Rivi\u00e8re PJ (2008) Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Eur J Pharmacol 583:62\u201372","journal-title":"Eur J Pharmacol"},{"key":"420_CR90","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI7613","volume":"104","author":"C Vestergaard","year":"1999","unstructured":"Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K (1999) Overproduction of Th2-specific chemokines in NC\/Nga mice exhibiting atopic dermatitis\u2013like lesions. J Clin Invest 104:1097\u20131105","journal-title":"J Clin Invest"},{"key":"420_CR91","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.lfs.2004.05.033","volume":"75","author":"Y Wakasa","year":"2004","unstructured":"Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, Nagase H (2004) Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci 75:2947\u20132957","journal-title":"Life Sci"},{"key":"420_CR92","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/jpet.104.073668","volume":"312","author":"Y Wang","year":"2005","unstructured":"Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DYW, Huang P, Li J-G, Cowan A, Liu-Chen L-Y (2005) Comparison of pharmacological activities of three distinct \u03ba ligands (salvinorin a, TRK-820 and 3FLB) on \u03ba opioid receptors in vitro and their antipruritic and Antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220\u2013230","journal-title":"J Pharmacol Exp Ther"},{"key":"420_CR93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2340\/00015555-3164","volume":"99","author":"E Weisshaar","year":"2019","unstructured":"Weisshaar E, Szepietowski JC, Dalgard F, Garcovich S, Gieler U, Gimenez-Arnau A, Lambert J, Leslie T, Mettang T, Misery L, Savk E, Streit M, Tschachler E, Wallengren J, St\u00e4nder S (2019) European S2k guideline on chronic pruritus. Acta Derm Venereol 99:469\u2013506","journal-title":"Acta Derm Venereol"},{"key":"420_CR94","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstr\u04e7m","year":"2005","unstructured":"Wikstr\u04e7m B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y (2005) Opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16:3742\u20133747","journal-title":"J Am Soc Nephrol"},{"key":"420_CR95","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00535-018-1465-z","volume":"53","author":"M Yagi","year":"2018","unstructured":"Yagi M, Tanaka A, Namisaki T, Takahashi A, Abe M, Honda A, Matsuzaki Y, Ohira H, Yoshiji H, Takikawa H (2018) Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study. J Gastroenterol 53:1151\u20131158","journal-title":"J Gastroenterol"},{"key":"420_CR96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2008.04.021","volume":"193","author":"I Yalcin","year":"2008","unstructured":"Yalcin I, Belzung C, Surget A (2008) Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav Brain Res 193:140\u2013143","journal-title":"Behav Brain Res"},{"key":"420_CR97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-0102(99)00070-X","volume":"35","author":"T Yamaguchi","year":"1999","unstructured":"Yamaguchi T, Nagasawa T, Satoh M, Kuraishi Y (1999) Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice. Neurosci Res 35:77\u201383","journal-title":"Neurosci Res"},{"key":"420_CR98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2007.02.062","volume":"565","author":"R Yatsuzuka","year":"2007","unstructured":"Yatsuzuka R, Inoue T, Jiang S, Nakano Y, Kamei C (2007) Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice. Eur J Pharmacol 565:225\u2013231","journal-title":"Eur J Pharmacol"},{"key":"420_CR99","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2826.2012.02381.x","volume":"25","author":"GLC Yosten","year":"2013","unstructured":"Yosten GLC, Lyu RM, Hsueh AJW, Avsian-Kretchmer O, Chang JK, Tullock CW, Dun SL, Dun N, Samson WK (2013) A novel reproductive peptide, phoenixin. J Neuroendocrinol 25:206\u2013215","journal-title":"J Neuroendocrinol"},{"key":"420_CR100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1159\/000373929","volume":"35","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yan J, Hu R, Sun Y, Ma Y, Chen Z, Jiang H (2015) Microglia are involved in pruritus induced by DNFB via the CX3CR1\/p38 MAPK pathway. Cell Physiol Biochem 35:1023\u20131033","journal-title":"Cell Physiol Biochem"}],"container-title":["Handbook of Experimental Pharmacology","The Kappa Opioid Receptor"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2020_420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T02:16:01Z","timestamp":1637806561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2020_420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030890735","9783030890742"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/164_2020_420","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"10 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}